Blunt Roy

SEC Form 4 insider trading activity

Blunt Roy has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Aug 8, 2026.

On the most recent filing, Blunt Roy is listed as Director at TENET HEALTHCARE CORP. Inside the rolling window, Blunt Roy reported no open-market purchases and 1 open-market sale totaling $158K in THC.

Companies traded

Other insiders at THC

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$158K

reported sales (SEC code S)

Companies

1

in the rolling window

Source
THC
Blunt Roy
Sale$158KAug 8SEC ↗

Frequently asked questions

How many SEC Form 4 filings has Blunt Roy made?

Blunt Roy has filed 2 SEC Form 4 filings (3 transaction rows) across 1 company since 2026.

Which companies does Blunt Roy trade?

Blunt Roy has filed SEC Form 4 disclosures for 1 company, including THC.

When was Blunt Roy's most recent SEC Form 4 filing?

Blunt Roy's most recent SEC Form 4 filing on Tracefour is dated Aug 8, 2026.

What is Blunt Roy's total buy and sell value in the current window?

Inside the rolling retention window, Blunt Roy bought $0 and sold $158K based on SEC Form 4 filings.

What was Blunt Roy's largest disclosed transaction?

The largest disclosed transaction in the current window is a sale of 600 THC shares on 2026-08-05, worth $158K, per SEC Form 4 filings.